NYSEARCA:IBRN iShares Neuroscience and Healthcare ETF (IBRN) Price, Holdings, & News $23.70 +0.49 (+2.11%) As of 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBRN alerts:Sign Up Key Stats Today's Range$23.37▼$23.7050-Day Range$21.78▼$23.8452-Week Range$17.86▼$28.74Volume791 shsAverage Volume791 shsMarket Capitalization$3.56 millionAssets Under Management$3.48 millionDividend Yield0.42%Net Expense Ratio0.47%Aggregate RatingModerate Buy ETF Overview The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock. Read More iShares Neuroscience and Healthcare ETF ExpensesTypeIBRNTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.47%0.57%0.56%0.51%0.53%Other Expenses0.00%0.57%0.56%0.59%0.56%Total Expense0.47%0.74%0.76%0.74%0.73%Fee Waiver0.00%-0.76%-0.66%-0.71%-0.63%Net Expense0.47%0.60%0.63%0.58%0.60% Receive IBRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBRN ETF News HeadlinesBlackRock, Inc. Expands Holdings in iShares Neuroscience and Healthcare ETFJanuary 8, 2025 | gurufocus.comSee More Headlines IBRN ETF - Frequently Asked Questions How have IBRN shares performed this year? iShares Neuroscience and Healthcare ETF's stock was trading at $25.40 at the beginning of 2025. Since then, IBRN shares have decreased by 6.7% and is now trading at $23.70. How do I buy shares of iShares Neuroscience and Healthcare ETF? Shares of IBRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssueriShares Fund NameiShares Neuroscience and Healthcare ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IBRN Inception Date8/24/2022 Fund ManagerJennifer Hsui, Greg Savage, Paul Whitehead, Amy Whitelaw WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE FactSet Global Neuro Biopharma and MedTech Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings63 Fund Statistics Assets Under Management$3.48 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerFlow Traders Options OptionableOptionable Options Volume3 Put Options1 Call Options3 Short Interest1,700 shs Miscellaneous Outstanding Shares150,000Beta1.36 Creation Unit50,000 Creation Fee$350.00 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report Top 10 IBRN Holdingsargenex (NASDAQ:ARGX)Holding Weight: 4.75%ACADIA Pharmaceuticals (NASDAQ:ACAD)Holding Weight: 4.41%Scholar Rock (NASDAQ:SRRK)Holding Weight: 4.39%Supernus Pharmaceuticals (NASDAQ:SUPN)Holding Weight: 4.35%Neurocrine Biosciences (NASDAQ:NBIX)Holding Weight: 4.24%SK Biopharmaceuticals Co., Ltd.Holding Weight: 4.15%PTC Therapeutics (NASDAQ:PTCT)Holding Weight: 4.14%Biogen (NASDAQ:BIIB)Holding Weight: 4.09%Xenon Pharmaceuticals (NASDAQ:XENE)Holding Weight: 3.97%Denali Therapeutics (NASDAQ:DNLI)Holding Weight: 3.77%Full Holdings DetailsIBRN Sector ExposureIBRN Industry Exposure This page (NYSEARCA:IBRN) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access